Project Number 5P50AG005136-26 Agency/Funding Organization NIA Funding Year 2009 View Full Project Details for GENETIC MAPPING OF LATE-ONSET ALZHEIMER'S DISEASE GENES Research Categorization Primary Disease / Condition Alzheimer's Disease CADRO Category A. Molecular Pathogenesis and Physiology of Alzheimer's Disease and Alzheimer's Disease-related Dementias (AD/ADRDs) 17. Genetics e. Nucleic acid-related "omics" Studies Category F. Research Resources 1. Alzheimer's Disease Centers Researcher and Organization Principal Investigator WIJSMAN, ELLEN M Principal Investigator First Name ELLEN M Principal Investigator Last Name WIJSMAN Awardee Organization UNIVERSITY OF WASHINGTON Awardee State Washington Contact PI Country United States Project Detail Funding Opportunity Announcement RFA-AG-04-011: ALZHEIMER’S DISEASE RESEARCH CENTERS FY Overall Cost $195,678 Funding Organization Agency/Funding Organization NIA Funding Organization Country United States Program Official SILVERBERG, NINA B Related Resources Repository [NIAGADS] Transethnic GWAS Summary Statistics - Jun et al. (2017) [NIAGADS] ADC1- Alzheimer Disease Center Dataset 1 [NIAGADS] ADC2- Alzheimer Disease Center Dataset 2 [NIAGADS] ADC3- Alzheimer Disease Center Dataset 3 [NIAGADS] ADGC African American Summary Statistics- Reitz et al. (2013) [NIAGADS] ADGC Neuropath Summary Stats and Phenotypes- Beecham et al. (2014) [NIAGADS] ADGC Summary Statistics- Naj et al. (2011) University of Washington Alzheimer's Disease Research Center National Alzheimer's Coordinating Center (NACC) [AlzPED] Latrepirdine improves cognition and arrests progression of neuropathology in an Alzheimer's mouse model Pagination Page 1 Next page ››